Filter
4556
Filtered Results: 4556
Text search:
priority
medicines
Featured
Recommendations
471
New Publications
1216
Language
Document type
No document type
2342
Studies & Reports
819
Guidelines
661
Manuals
283
Strategic & Response Plan
250
Training Material
74
Fact sheets
56
Situation Updates
44
Resource Platforms
12
Infographics
7
Brochures
5
Online Courses
3
Countries / Regions
Global
209
India
166
Kenya
141
Ethiopia
100
South Africa
99
Nepal
97
Sierra Leone
89
Uganda
86
Nigeria
84
Liberia
81
Western and Central Europe
76
Africa
74
Latin America and the Carribbean
74
Bangladesh
70
Zambia
67
Malawi
64
Ghana
58
Tanzania
58
Myanmar / Burma
58
Ukraine
53
Syria
53
Rwanda
47
Congo, Democratic Republic of
42
Namibia
41
Philippines
31
Eastern Europe
31
Haiti
30
South–East Asia Region
30
Asia
29
Lesotho
27
Zimbabwe
27
Mozambique
27
Senegal
24
Guinea
24
Cambodia
23
South Sudan
21
Burkina Faso
20
Botswana
20
Indonesia
18
West and Central Africa
17
Middle East and North Africa
17
Eastern Europe and Central Asia
17
East and Southern Africa
17
Yemen
17
Benin
16
Cameroon
16
Germany
14
Sudan
14
Pakistan
14
Afghanistan
13
Venezuela
13
Madagascar
13
Russia
12
Moldova
11
Thailand
10
Lebanon
9
Vietnam
9
Somalia
9
Eswatini/ Swaziland
9
USA
8
Jordan
8
Western Pacific Region
8
Brazil
8
Tajikistan
7
Albania
7
Laos
7
Côte d’Ivoire / Ivory Coast
7
Georgia
7
Mali
7
China
6
Sri Lanka
6
Central African Republic
6
Ecuador
6
Colombia
5
Turkey
5
Niger
5
Peru
5
North America
5
Bolivia
5
Iraq
5
Timor Leste/ East Timor
4
Kazakhstan
4
Iran
4
Burundi
4
Saudi Arabia
4
Turkmenistan
4
United Kingdom
4
Palestine
4
North Macedonia
3
Togo
3
Chile
3
Kyrgyzstan
3
Hungary
3
Jamaica
3
France
3
Mauritius
3
Southern Africa
3
Papua New Guinea
3
Egypt
3
Poland
3
Libya
3
Bhutan
3
El Salvador
2
Serbia
2
Canada
2
Fiji
2
Estonia
2
Congo-Brazzaville
2
Uzbekistan
2
Morocco
2
Qatar
2
Bulgaria
2
Lithuania
2
Gabon
2
Tunisia
2
Belarus
2
Argentina
2
Nicaragua
2
Romania
2
Angola
2
Chad
2
Guatemala
2
Switzerland
1
Gambia
1
Mongolia
1
Mauritania
1
Armenia
1
Dominican Republic
1
Guinea-Bissau
1
Paraguay
1
Japan
1
Denmark
1
Maldives
1
French Guyana
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Djibouti
1
Slovakia
1
Greece
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
1685
Clinical Guidelines
397
Public Health
280
Women & Child Health
241
Key Resources
227
Capacity Building
80
Pharmacy & Technologies
49
Annual Report MEDBOX
2
Toolboxes
HIV
413
COVID-19
361
Mental Health
303
TB
265
AMR
228
Caregiver
146
Disability
124
Conflict
120
NTDs
115
Pharmacy
114
Ebola & Marburg
112
Planetary Health
109
NCDs
89
Global Health Education
87
Rapid Response
82
Malaria
76
Health Financing Toolbox
67
Natural Hazards
55
Refugee
51
2.0 Rapid Response
45
Zika
20
Specific Hazards
17
Cholera
17
Social Ethics
16
Polio
14
Typhoon
1
Women and girls are paying the price of the war in Yemen – Humanitarian actors must increase the priority given to women and girls’ needs, with specific attention to GBV prevention and response, and reproductive health services
How WHO works to prevent drug use, reduce harm and improve safe access to medicines
The full-scale invasion of Ukraine has caused a deterioration in the level of access to health-care services and medicines in the country, particularly for people living in regions close to the front line and areas that are not partially or fully controlled by the Government of Ukraine, and for peop...
Fact Book on WHO Level I and Level II monitoring indicators - To monitor the progress of efforts to improve the global medicines situation, WHO has developed a system of indicators that measure important aspects of a country’s pharmaceutical situation. Level 1 indicators measure the existence and ...
An all-hazards tool for hospital administrators and emergency managers.
The World Health Organization Regional Office for Europe has developed the Hospital emergency response checklist to assist hospital administrators and emergency managers in responding effectively to the most likely disaster sce...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration and Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
The pre-clinical pipeline shows more innovation and diversity, with 252 agents being developed to treat WHO priority pathogens.
However, these products are in the very early stages of development and still need to be proven effective and safe. The optimistic scenario, the report indicates, is for...
Rabies is entirely preventable, and vaccines, medicines, tools and technologies have long been available to prevent people from dying of dog-mediated rabies. Nevertheless, rabies still kills about 60 000 people a year, of whom over 40% are children under 15, mainly in rural areas of economically dis...
Since the introduction of penicillin in the early twentieth century, antimicrobial treatments have been utilized not only in human medicine but also in veterinary care – initially to ward off diseases, prevent post-surgery infections, and treat sick farm animals.Global food production...
14 March 2022. Ukraine emergency response
WHO appreciates offers of contributions of supply support in solidarity with the affected population of the current conflict in Ukraine.
Please note that supply into and within Ukraine is seriously constrained by continuously shifting conflict zones, d...
Primary Health-Care Services
recommended
In health emergencies as in periods of stability, restoring access to primary health-care services is a priority in so far as many health problems can be dealt with by means of preventive care and
conventional therapy. Depending on the context, the ICRC must often take action in this area, taking i...
The Multi-professional Patient Safety Curriculum Guide (2011) was developed to assist in the teaching of patient safety in universities and schools in the fields of dentistry, medicine, midwifery, nursing and pharmacy. It also supports the on-going training of all health care professionals.
The C...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve...
Antimicrobial resistance (AMR) is a global threat that requires urgent collaborative action within and among countries. AMR makes standard treatments ineffective and facilitates the spread of antimicrobial resistant infections rendering communities vulnerable. The Ministry of Health (MOH) and Minist...
At least half of the world’s population does not have full coverage of essential health services. Health expenses push more than 100 million people into extreme poverty each and every year, forcing them into terrible choices that no one should ever have to make: Buy medicine or food? Education or ...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr...
Healthy communities rely on well-functioning ecosystems. They provide clean air, fresh water, medicines and food security. They also limit disease and stabilize the climate. But biodiversity loss is happening at unprecedented rates, impacting human health worldwide, according to a new state of knowl...
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outline...
